{"id":837179,"date":"2025-04-14T17:05:14","date_gmt":"2025-04-14T21:05:14","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/cue-biopharma-to-host-business-update-call-and-webcast-6\/"},"modified":"2025-04-14T17:05:14","modified_gmt":"2025-04-14T21:05:14","slug":"cue-biopharma-to-host-business-update-call-and-webcast-6","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/cue-biopharma-to-host-business-update-call-and-webcast-6\/","title":{"rendered":"Cue Biopharma to Host Business Update Call and Webcast"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">BOSTON, April  14, 2025  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=3OyhRdBOvJY9omPx5Scwe8lle4CQg-YXPx_NUAt4xTZN8uzgKnNpp5PlIRyJGTcxmrfRrES0KOi5s5hiv8lpTgKBTAe3qDModhYNP6-b--U=\" rel=\"nofollow\" target=\"_blank\">Cue Biopharma, Inc.<\/a>\u00a0(Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the treatment of cancer and autoimmune disease, today announced that it will host a conference call and webcast to provide a business update on Tuesday, April 15, 2025 at 4:30 p.m. ET.<\/p>\n<p align=\"left\">\n        <strong>Conference Call and Webcast Details<\/strong><br \/>\n        <br \/>\n        <strong>Tuesday, April 15 at 4:30 p.m. ET<\/strong>\n      <\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"vertical-align: top\">\n            <strong>Investors:<\/strong>\n          <\/td>\n<td style=\"vertical-align: top\">1-844-826-3035<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">\n            <strong>International Investors:<\/strong>\n          <\/td>\n<td style=\"vertical-align: top\">1-412-317-5195<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">\n            <strong>Conference ID:<\/strong>\n          <\/td>\n<td style=\"vertical-align: top\">10199037<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">\n            <strong>Webcast Link:<\/strong>\n          <\/td>\n<td style=\"vertical-align: top\">\n            <a href=\"https:\/\/nam04.safelinks.protection.outlook.com\/?url=https%3A%2F%2Fviavid.webcasts.com%2Fstarthere.jsp%3Fei%3D1715808%26tp_key%3D9378826572&amp;data=05%7C02%7Cmromanchuk%40lifescicomms.com%7Cfe8f49e85ba240fae5dd08dd78ff35bb%7C65ec683a30ce43d0a6ef2fd46d0f5e8a%7C0%7C0%7C638799759699673822%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&amp;sdata=IbJYKLOcob%2BtteFdLnRngITwuPBsKqf1a8KB123zqLE%3D&amp;reserved=0\" rel=\"nofollow\" target=\"_blank\">https:\/\/viavid.webcasts.com\/starthere.jsp?ei=1715808&amp;tp_key=9378826572<\/a>\n          <\/td>\n<\/tr>\n<\/table>\n<p>\n        <em>The live and archived webcast will also be available in the Investors and Media section of the Company\u2019s <\/em><br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=fzUsfZMFOb-2kLXZSma7VLSchk8l8rck0UzdCs3xI4KRJEnyLqkNnGESg0E9MJ1YIunY1AEnC5TvdmO94XtGX6X9tp-Fr7kPRkSzCk8FmyU1yrUl5Xf3LhY_05PqedUnfjRRaifbd7UiUuxgFaJvMg==\" rel=\"nofollow\" target=\"_blank\"><br \/>\n          <em>website<\/em><br \/>\n        <\/a><br \/>\n        <em>. The webcast will be archived for 30 days. <\/em><\/p>\n<p>        <strong>About\u00a0Cue Biopharma<\/strong><br \/>\n        <br \/>Cue Biopharma, a clinical-stage biopharmaceutical company, is developing a novel class of injectable biologics to selectively engage and modulate disease-specific T cells directly within the patient\u2019s body. The company\u2019s proprietary platform, Immuno-STAT\u2122 <em>(Selective Targeting and Alteration of T cells)<\/em>, and biologics are designed to harness the curative potential of the body\u2019s intrinsic immune system through the selective modulation of disease-specific T cells without the adverse effects of broad systemic immune modulation.<\/p>\n<p>Headquartered in\u00a0Boston, Massachusetts, we are led by an experienced management team with deep expertise in immunology and protein engineering as well as the design and clinical development of protein biologics. <\/p>\n<p>For more information please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=uDvD80HFgaFXYzaVVYJxj8X2GL3wjRxPRTOSFN42KmWo0-773RrjyKVONf_8Xx9QRWlKvSDy7WeHMA2-PWoKxshCRyQbQU-1Na1Dt2Af7Os=\" rel=\"nofollow\" target=\"_blank\">www.cuebiopharma.com<\/a>\u00a0and follow us on\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ihzALPaNClcdCXOqApEtQaD0nmPGs7nMs-nLOekV9jcI3xkEWUKZ1RIujHHkOO7Mjg6zJR7lXnVxPplKoBKNfVIr-Vj5KdLHG2UFKhi79VHTHtNajl-3tknlrAh_by4UFPcH6t4oP0HcfQWQZKN9tYX1l4z82ZGFKdtsN507fJPZAKGVUZfRerGC1AZ5jUZoXVi6rsQONY1elzMwESfxKzzjsMCKFcXDDwUmg2ykeA7nPSDWGhLaDXpCoYkl02JxajGlxHxwoOCmbqtNr3_bhm9TP2EvuYAhRpHpmTYJzHxCJa0getHSgNDSx-_ZmcoUBiY0cOd5G5PRgW12N60BQrUNpPEDhF1NvVArL_7Keow88Dfx_Uyt8DIwf2H_DjuzCtZBRZBPF8HqxjfI3w1ZaR63zquS37iOifbc_0PR7wT1KiZEIY8gwq4h2PoQsvx6Gg8lnkbZs8XpG7-f2cU2WQ==\" rel=\"nofollow\" target=\"_blank\">X<\/a> and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=2INlTzj3QyiwUhudCaiw1_xopHiFImiw_tMeUOjGKKomjgsXF2SjA9QlFo_n1KfOExeUORtMsB7JRfVzrWit_tVxXnQD-Dmb69IAVy-iX2tLmmAv7RVDXRGm_OqJZvW_gFwF5lQqUQbDa7ZKRXoDOE7UoiYb7U7bGO3X5REOT8LdqpCjfCsQDnRphVnVdei7_Pzyz_81BrBu0r8Gy_fypqlAH2k79P9QAyIxxXApoyf_AI6WEBkA5_9WkD57p2SW\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a>.<\/p>\n<p>\n        <strong>Investor Contact <\/strong><br \/>\n        <br \/>Marie Campinell\u00a0<br \/>Senior Director, Corporate Communications<br \/>Cue Biopharma, Inc.<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=r86_RnaigFdvLABrnObgVFRsFnXtrNXHhFN3nahX8ZzYS0Ps5EHt6BdnkNfLAsqitVmUCLQ6qI5zc8vBpwpT2uxE0fWz8zjYd29inPoTz18=\" rel=\"nofollow\" target=\"_blank\">mcampinell@cuebio.com<\/a><\/p>\n<p>\n        <strong>Media Contact<\/strong><br \/>\n        <br \/>Jonathan Pappas<br \/>LifeSci Communications<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=sKGFSokzwyd_ulF5eSJFsgJ5SadlzZ9pR383Wlh5W8-tIu2pdXUq4LL0vZl3qhnLDDqL7vqu9RTKa7VPcVVgKFxjMY6ck4QkVJaE04Ob1lqSQCphJTZHrRn7T-ofGyyq\" rel=\"nofollow\" target=\"_blank\">jpappas@lifescicomms.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQyMjE1NiM2ODY1OTk4IzIwOTI2OTI=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NWVkZjkyMzQtYWMxMy00MWVjLTljZWYtN2IwYzhlMjdkZTQ4LTExMDQyNjMtMjAyNS0wNC0xNC1lbg==\/tiny\/Cue-Biopharma-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>BOSTON, April 14, 2025 (GLOBE NEWSWIRE) &#8212; Cue Biopharma, Inc.\u00a0(Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the treatment of cancer and autoimmune disease, today announced that it will host a conference call and webcast to provide a business update on Tuesday, April 15, 2025 at 4:30 p.m. ET. Conference Call and Webcast Details Tuesday, April 15 at 4:30 p.m. ET Investors: 1-844-826-3035 International Investors: 1-412-317-5195 Conference ID: 10199037 Webcast Link: https:\/\/viavid.webcasts.com\/starthere.jsp?ei=1715808&amp;tp_key=9378826572 The live and archived webcast will also be available in the Investors and Media section of the Company\u2019s website . The webcast will be archived for 30 days. About\u00a0Cue Biopharma Cue Biopharma, a clinical-stage &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cue-biopharma-to-host-business-update-call-and-webcast-6\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Cue Biopharma to Host Business Update Call and Webcast&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-837179","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Cue Biopharma to Host Business Update Call and Webcast - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cue-biopharma-to-host-business-update-call-and-webcast-6\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cue Biopharma to Host Business Update Call and Webcast - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BOSTON, April 14, 2025 (GLOBE NEWSWIRE) &#8212; Cue Biopharma, Inc.\u00a0(Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the treatment of cancer and autoimmune disease, today announced that it will host a conference call and webcast to provide a business update on Tuesday, April 15, 2025 at 4:30 p.m. ET. Conference Call and Webcast Details Tuesday, April 15 at 4:30 p.m. ET Investors: 1-844-826-3035 International Investors: 1-412-317-5195 Conference ID: 10199037 Webcast Link: https:\/\/viavid.webcasts.com\/starthere.jsp?ei=1715808&amp;tp_key=9378826572 The live and archived webcast will also be available in the Investors and Media section of the Company\u2019s website . The webcast will be archived for 30 days. About\u00a0Cue Biopharma Cue Biopharma, a clinical-stage &hellip; Continue reading &quot;Cue Biopharma to Host Business Update Call and Webcast&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/cue-biopharma-to-host-business-update-call-and-webcast-6\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-14T21:05:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQyMjE1NiM2ODY1OTk4IzIwOTI2OTI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cue-biopharma-to-host-business-update-call-and-webcast-6\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cue-biopharma-to-host-business-update-call-and-webcast-6\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Cue Biopharma to Host Business Update Call and Webcast\",\"datePublished\":\"2025-04-14T21:05:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cue-biopharma-to-host-business-update-call-and-webcast-6\\\/\"},\"wordCount\":274,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cue-biopharma-to-host-business-update-call-and-webcast-6\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQyMjE1NiM2ODY1OTk4IzIwOTI2OTI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cue-biopharma-to-host-business-update-call-and-webcast-6\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cue-biopharma-to-host-business-update-call-and-webcast-6\\\/\",\"name\":\"Cue Biopharma to Host Business Update Call and Webcast - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cue-biopharma-to-host-business-update-call-and-webcast-6\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cue-biopharma-to-host-business-update-call-and-webcast-6\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQyMjE1NiM2ODY1OTk4IzIwOTI2OTI=\",\"datePublished\":\"2025-04-14T21:05:14+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cue-biopharma-to-host-business-update-call-and-webcast-6\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cue-biopharma-to-host-business-update-call-and-webcast-6\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cue-biopharma-to-host-business-update-call-and-webcast-6\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQyMjE1NiM2ODY1OTk4IzIwOTI2OTI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQyMjE1NiM2ODY1OTk4IzIwOTI2OTI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cue-biopharma-to-host-business-update-call-and-webcast-6\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cue Biopharma to Host Business Update Call and Webcast\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cue Biopharma to Host Business Update Call and Webcast - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/cue-biopharma-to-host-business-update-call-and-webcast-6\/","og_locale":"en_US","og_type":"article","og_title":"Cue Biopharma to Host Business Update Call and Webcast - Market Newsdesk","og_description":"BOSTON, April 14, 2025 (GLOBE NEWSWIRE) &#8212; Cue Biopharma, Inc.\u00a0(Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the treatment of cancer and autoimmune disease, today announced that it will host a conference call and webcast to provide a business update on Tuesday, April 15, 2025 at 4:30 p.m. ET. Conference Call and Webcast Details Tuesday, April 15 at 4:30 p.m. ET Investors: 1-844-826-3035 International Investors: 1-412-317-5195 Conference ID: 10199037 Webcast Link: https:\/\/viavid.webcasts.com\/starthere.jsp?ei=1715808&amp;tp_key=9378826572 The live and archived webcast will also be available in the Investors and Media section of the Company\u2019s website . The webcast will be archived for 30 days. About\u00a0Cue Biopharma Cue Biopharma, a clinical-stage &hellip; Continue reading \"Cue Biopharma to Host Business Update Call and Webcast\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/cue-biopharma-to-host-business-update-call-and-webcast-6\/","og_site_name":"Market Newsdesk","article_published_time":"2025-04-14T21:05:14+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQyMjE1NiM2ODY1OTk4IzIwOTI2OTI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cue-biopharma-to-host-business-update-call-and-webcast-6\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cue-biopharma-to-host-business-update-call-and-webcast-6\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Cue Biopharma to Host Business Update Call and Webcast","datePublished":"2025-04-14T21:05:14+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cue-biopharma-to-host-business-update-call-and-webcast-6\/"},"wordCount":274,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cue-biopharma-to-host-business-update-call-and-webcast-6\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQyMjE1NiM2ODY1OTk4IzIwOTI2OTI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cue-biopharma-to-host-business-update-call-and-webcast-6\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/cue-biopharma-to-host-business-update-call-and-webcast-6\/","name":"Cue Biopharma to Host Business Update Call and Webcast - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cue-biopharma-to-host-business-update-call-and-webcast-6\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cue-biopharma-to-host-business-update-call-and-webcast-6\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQyMjE1NiM2ODY1OTk4IzIwOTI2OTI=","datePublished":"2025-04-14T21:05:14+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cue-biopharma-to-host-business-update-call-and-webcast-6\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/cue-biopharma-to-host-business-update-call-and-webcast-6\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cue-biopharma-to-host-business-update-call-and-webcast-6\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQyMjE1NiM2ODY1OTk4IzIwOTI2OTI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQyMjE1NiM2ODY1OTk4IzIwOTI2OTI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cue-biopharma-to-host-business-update-call-and-webcast-6\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Cue Biopharma to Host Business Update Call and Webcast"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/837179","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=837179"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/837179\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=837179"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=837179"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=837179"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}